• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿立哌唑治疗失败后换用利培酮对急性精神分裂症患者血浆单胺代谢产物水平的影响

Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.

作者信息

Miura Itaru, Takeuchi Satoshi, Katsumi Akihiko, Kanno Keiko, Watanabe Kenya, Mashiko Hirobumi, Niwa Shin-Ichi

机构信息

Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.

出版信息

Hum Psychopharmacol. 2012 Sep;27(5):517-20. doi: 10.1002/hup.2251. Epub 2012 Aug 23.

DOI:10.1002/hup.2251
PMID:22927115
Abstract

OBJECTIVE

In the treatment of acute schizophrenia, risperidone and aripiprazole are both placed the first line antipsychotics. These two antipsychotics have different pharmacological effects. We investigated the effects of risperidone on plasma levels of homovanillic acid (HVA) and 3-methoxy-4hydroxyphenylglycol after unsuccessful aripiprazole treatment in acute schizophrenia.

METHODS

Ten Japanese patients with acute schizophrenia were enrolled to this study. Plasma levels of monoamine metabolites were analyzed with high-performance liquid chromatography with electrochemical detection.

RESULTS

Risperidone improved the symptoms and 4 of 10 patients were responders. Risperidone showed a tendency to decrease plasma HVA (pHVA) levels in responders (p = 0.068), but not in non-responders (p = 1.0). At baseline, pHVA levels of responders were significantly higher than that of non-responders (p = 0.033). A trend for negative correlation was found between pHVA at baseline and the changes in Positive and Negative Syndrome Scale-Total (p = 0.061, r = -0.61).

CONCLUSION

Our results suggest that high pHVA level before switching may predict good response to the second line antipsychotics after unsuccessful first antipsychotic treatment. If aripiprazole is not effective in acute schizophrenia, switching to risperidone may be effective and reasonable strategy for improving symptoms.

摘要

目的

在急性精神分裂症的治疗中,利培酮和阿立哌唑均被列为一线抗精神病药物。这两种抗精神病药物具有不同的药理作用。我们研究了在急性精神分裂症患者阿立哌唑治疗失败后,利培酮对血浆高香草酸(HVA)和3-甲氧基-4-羟基苯乙二醇水平的影响。

方法

十名日本急性精神分裂症患者纳入本研究。采用高效液相色谱电化学检测法分析单胺代谢产物的血浆水平。

结果

利培酮改善了症状,10名患者中有4名有效。利培酮在有效者中显示出血浆HVA(pHVA)水平有下降趋势(p = 0.068),但在无效者中无此趋势(p = 1.0)。基线时,有效者的pHVA水平显著高于无效者(p = 0.033)。在基线时的pHVA与阳性和阴性症状量表总分的变化之间发现有负相关趋势(p = 0.061,r = -0.61)。

结论

我们的结果表明,换药前高pHVA水平可能预示着在第一种抗精神病药物治疗失败后对第二种抗精神病药物有良好反应。如果阿立哌唑对急性精神分裂症无效,换用利培酮可能是改善症状的有效且合理策略。

相似文献

1
Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.阿立哌唑治疗失败后换用利培酮对急性精神分裂症患者血浆单胺代谢产物水平的影响
Hum Psychopharmacol. 2012 Sep;27(5):517-20. doi: 10.1002/hup.2251. Epub 2012 Aug 23.
2
Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia.精神分裂症患者抗精神病药物换用阿立哌唑或布南色林与血浆单胺代谢物水平
Hum Psychopharmacol. 2014 Mar;29(2):199-202. doi: 10.1002/hup.2386. Epub 2014 Jan 8.
3
Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.阿立哌唑和多巴胺 D2 受体基因 Taq1A 多态性对精神分裂症急性期临床反应和血浆单胺代谢物水平的影响。
J Clin Psychopharmacol. 2012 Feb;32(1):106-9. doi: 10.1097/JCP.0b013e31823f87ac.
4
An open study of risperidone liquid in the acute phase of schizophrenia.利培酮口服液治疗精神分裂症急性期的开放性研究。
Hum Psychopharmacol. 2005 Jun;20(4):243-8. doi: 10.1002/hup.685.
5
Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.阿立哌唑改变了首发未治疗的日本精神分裂症患者血浆中脑源性神经营养因子和儿茶酚胺代谢物的水平。
Hum Psychopharmacol. 2012 Jan;27(1):33-8. doi: 10.1002/hup.1257. Epub 2011 Dec 30.
6
Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.首发精神分裂症患者临床亚组中的血浆高香草酸差异
Psychiatry Res. 2009 Jul 30;168(2):110-8. doi: 10.1016/j.psychres.2008.04.011. Epub 2009 Jun 6.
7
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.阿立哌唑,一种具有新型作用机制的抗精神病药物,与利培酮相比,用于治疗精神分裂症和分裂情感性障碍患者时对照安慰剂。
Arch Gen Psychiatry. 2003 Jul;60(7):681-90. doi: 10.1001/archpsyc.60.7.681.
8
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.首发未治疗精神分裂症患者应用非典型抗精神病药物后儿茶酚胺代谢物和脑源性神经营养因子的血浆水平纵向变化的不同模式。
World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):256-61. doi: 10.3109/15622970802309617.
9
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.换用阿立哌唑后抗精神病药物所致高催乳素血症变化的时间进程。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1978-81. doi: 10.1016/j.pnpbp.2008.09.016. Epub 2008 Sep 30.
10
The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.阿立哌唑与利培酮治疗精神分裂症的神经认知效应比较。
Hiroshima J Med Sci. 2012 Dec;61(4):75-83.

引用本文的文献

1
Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic Review.精神分裂症患者口服突触后抗多巴胺能抗精神病药物之间转换的策略:一项系统综述
CNS Drugs. 2025 Jul 23. doi: 10.1007/s40263-025-01206-3.
2
Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.阿戈美拉汀在脂多糖诱导的与精神病相关行为模型中的保护作用。
Med Sci Monit. 2015 Dec 8;21:3834-9. doi: 10.12659/msm.895505.